TickerFacts.

Turn Therapeutics Inc. (TTRX): Cash & Equivalents

Annual figures by period end, from SEC filings.

$4.03M
As of 2025-12-31
$9.95M
As of 2026-06-30
2024-12-31: $498.3K2025-12-31: $4.03M$4.03M
2024-12-31 Cash & Equivalents (USD) 2025-12-31
Period endedCash & EquivalentsChange YoYSource filing
2025-12-31$4.03M+708.3%2026-03-31, Balance as of period end
2024-12-31$498.3Kn/a2026-03-31, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCash & EquivalentsChange YoY
Turn Therapeutics Inc. (TTRX)2025-12-31$4.03M+708.3%
Anebulo Pharmaceuticals, Inc. (ANEB)2025-06-30$11.63M+275.8%
Imunon, Inc. (IMNN)2025-12-31$8.78M+49.5%
PRF Technologies Ltd. (PRFX)2025-12-31$3.12M-26.7%
Revelation Biosciences, Inc. (REVB)2025-12-31$10.70M+64.6%
Curanex Pharmaceuticals Inc (CURX)2025-12-31$5.00Mn/a
PMGC Holdings Inc. (ELAB)2024-12-31$3.98M+19.8%
NewcelX Ltd. (NCEL)2025-12-31$2.20M+238.6%
NRX Pharmaceuticals, Inc. (NRXP)2025-12-31$7.80M+440.3%

Compare TTRX, ANEB, IMNN, PRFX side by side · Screen every company in Pharmaceutical Preparations ↗